Nanalysis Scientific Corp.
NSCIF
$0.1853
$0.00241.31%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 33.19M | 31.62M | 29.11M | 25.91M | 21.08M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.19M | 31.62M | 29.11M | 25.91M | 21.08M |
| Cost of Revenue | 23.91M | 24.06M | 22.60M | 21.18M | 18.14M |
| Gross Profit | 9.28M | 7.55M | 6.52M | 4.72M | 2.94M |
| SG&A Expenses | 8.25M | 8.36M | 8.54M | 8.74M | 9.20M |
| Depreciation & Amortization | 3.18M | 3.14M | 3.13M | 3.19M | 3.24M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.74M | 35.85M | 34.62M | 33.48M | 31.08M |
| Operating Income | -2.54M | -4.23M | -5.50M | -7.58M | -10.00M |
| Income Before Tax | -9.87M | -5.37M | -8.94M | -10.73M | -12.47M |
| Income Tax Expenses | -15.60K | 725.50K | 633.10K | 405.20K | -14.70K |
| Earnings from Continuing Operations | -9.86 | -6.09 | -9.58 | -11.14 | -12.46 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | 0.00 | 0.00 | 166.00K | 435.90K |
| Net Income | -9.86M | -6.09M | -9.58M | -10.97M | -12.02M |
| EBIT | -2.54M | -4.23M | -5.50M | -7.58M | -10.00M |
| EBITDA | -1.79M | -3.44M | -4.07M | -5.42M | -7.13M |
| EPS Basic | -0.09 | -0.06 | -0.09 | -0.11 | -0.12 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.04 | -0.05 | -0.06 |
| EPS Diluted | -0.09 | -0.06 | -0.09 | -0.11 | -0.12 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.04 | -0.05 | -0.06 |
| Average Basic Shares Outstanding | 442.52M | 430.88M | 419.21M | 405.38M | 396.63M |
| Average Diluted Shares Outstanding | 442.52M | 430.88M | 419.21M | 405.38M | 396.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |